Q4 2023 Holdings
Filed 2024-02-14 | 36 holdings | $1.6B | 13F-HR | View on SEC ↗ · Holdings Table ↗
Sign in to see sub-manager breakdown
| Issuer | Class | CUSIP | Value ↓ | Shares | % Portfolio |
|---|---|---|---|---|---|
| Brookfield Corp(BN) | CL A LTD VT SH | 11271J107 | $155.7M | 3,880,230 | 9.6% |
| Asml Holding N V(ASML) | N Y REGISTRY SHS | N07059210 | $149.7M | 197,760 | 9.2% |
| Salesforce.com, Inc.(CRM) | COM | 79466L302 | $139.6M | 530,500 | 8.6% |
| Spero Therapeutics Inc(SPRO) | COM | 84833T103 | $123.4M | 468,902 | 7.6% |
| Lanzatech Global Inc | COM | 51655R101 | $79.5M | 15,814,845 | 4.9% |
| Corcept Therapeutics Inc(CORT) | COM | 218352102 | $78.3M | 2,411,362 | 4.8% |
| Taiwan Semiconductor MFG LTD(TSM) | SPONSORED ADS | 874039100 | $73.9M | 710,780 | 4.6% |
| Edgewise Therapeutics Inc(EWTX) | COM | 28036F105 | $66.4M | 6,071,703 | 4.1% |
| Cable One Inc(CABO) | COM | 12685J105 | $65.9M | 118,403 | 4.1% |
| Vaxcyte Inc(PCVX) | COM | 92243G108 | $53.1M | 845,000 | 3.3% |
| Mirum Pharmaceuticals Inc(MIRM) | COM | 604749101 | $44.3M | 1,500,000 | 2.7% |
| Biomarin Pharmaceutical Inc(BMRN) | COM | 09061G101 | $43.4M | 450,000 | 2.7% |
| Pharvaris N V(PHVS) | COM | N69605108 | $43.2M | 1,539,325 | 2.7% |
| Apple Inc(AAPL) | COM | 037833100 | $42.6M | 221,460 | 2.6% |
| Insmed Inc(INSM) | COM PAR $.01 | 457669307 | $41.5M | 1,339,304 | 2.6% |
| Crinetics Pharmaceuticals in(CRNX) | COM | 22663K107 | $39.1M | 1,100,000 | 2.4% |
| Alibaba Group Hldg LTD(BABA) | SPONSORED ADS | 01609W102 | $38.8M | 500,827 | 2.4% |
| Amicus Therapeutics Inc(FOLD) | COM | 03152W109 | $35.5M | 2,500,000 | 2.2% |
| Blueprint Medicines Corp(2L9) | COM | 09627Y109 | $33.1M | 359,126 | 2.0% |
| Rocket Pharmaceuticals Inc(RCKT) | COM | 77313F106 | $31.5M | 1,050,000 | 1.9% |
| 4D Molecular Therapeutics in(FDMT) | COM | 35104E100 | $30.4M | 1,500,000 | 1.9% |
| Cargo Therapeutics Inc(CRGX) | COM | 14179K101 | $28.9M | 1,250,000 | 1.8% |
| Verve Therapeutics Inc | COM | 92539P101 | $27.9M | 2,000,000 | 1.7% |
| Brookfield Asset Managmt LTD(BAM) | CL A LMT VTG SHS | 113004105 | $25.2M | 627,207 | 1.6% |
| Alnylam Pharmaceuticals Inc(ALNY) | COM | 02043Q107 | $22.7M | 118,383 | 1.4% |
| Cymabay Therapeutics Inc(CBAYUSD) | COM | 23257D103 | $21.3M | 900,000 | 1.3% |
| Spruce Biosciences Inc | COM | 85209E109 | $19.7M | 6,722,336 | 1.2% |
| Lexeo Therapeutics Inc(LXEO) | COM | 52886X107 | $17.6M | 1,307,829 | 1.1% |
| Inspire MED SYS Inc(INSP) | COM | 457730109 | $13.3M | 65,524 | 0.8% |
| IO Biotech Inc(IOBT) | COM | 449778109 | $10.8M | 5,747,067 | 0.7% |
| Abcellera Biologics Inc(ABCL) | COM | 00288U106 | $6.4M | 1,126,915 | 0.4% |
| Treace MED Concepts Inc(TMCI) | COM | 89455T109 | $4.6M | 360,000 | 0.3% |
| Rallybio Corp | COM | 75120L100 | $4.2M | 1,767,861 | 0.3% |
| Marqeta Inc(MQ) | CLASS A COM | 57142B104 | $3.1M | 441,558 | 0.2% |
| Lava Therapeutics NV | SHS | N51517105 | $3.0M | 1,878,194 | 0.2% |
| Galecto Inc(GLTOUSD) | COM | 36322Q107 | $1.8M | 2,497,791 | 0.1% |